During the 2024 National People's Congress and the National People's Congress, Chang Juping, a representative of the National People's Congress, submitted".Regarding the amendment of some provisions of the "Blood Donation Law of the People's Republic of China".It is recommended to amend some provisions of the "Blood Donation Law" accordingly, scientifically define and clarify the scope of use of unqualified blood tested by blood stations, formulate management regulations on the packaging, storage, transportation, utilization and supervision of unqualified blood, and further improve China's unpaid blood donation system.
During the two sessions of the National People's Congress in 2024, the deputies to the National People's Congress in Shenzhen also brought the topics they were concerned about, and submitted them to Chang Juping, a deputy to the National People's Congress in Shenzhen".Regarding the amendment of some provisions of the "Blood Donation Law of the People's Republic of China".". Chang Juping believes that the current implementation of the "Blood Donation Law of the People's Republic of China" (hereinafter referred to as the "Blood Donation Law") has been implemented since October 1, 1998, which has greatly promoted the healthy development of China's unpaid blood donation system.
According to the survey, among the blood donated by blood donors, the scrap rate of unqualified blood in blood stations is between 3% and 5% every year due to unqualified infectious disease indicators, as well as damaged packaging, fat blood, hemolysis, insufficient blood volume, etc. Based on the national blood collection volume in 2021, the number of non-positive blood scrapped at blood stations in that year was about 114 tons. For a long time, China's blood collection industry has strictly followed the provisions of the "Blood Donation Law" to provide qualified blood for the clinical needs of medical institutions, and the blood that fails to pass the blood test by the blood station has not been effectively used for any other purposes, and is all disposed of in accordance with the "Medical Waste Management System". This not only consumes a lot of manpower, material and financial resources, but also wastes precious biological resources and restricts the development of the biomedical industry.
The reality of blood utilization is that at present, more than 90% of the quality controls and calibrators in the IVD industry rely on imports, which not only costs a certain amount of foreign exchange every year, but also that once Europe and the United States and other countries restrict exports, the relevant industries will be greatly affected or even wiped out. From a technical point of view, the non-test positive waste blood in the unqualified blood tested by the blood bank can meet the needs of IVD in China to a large extent, if these unqualified blood is allowed to be used for the preparation of in vitro diagnostic quality controls and calibrators, it can greatly reduce the dependence of related products on Europe and the United States and other countries, thereby greatly promoting the independent development of China's blood research products. Therefore, Chang Juping suggested that some provisions of the Blood Donation Law should be amended accordingly, scientifically define and clarify the scope of use of unqualified blood tested by blood stations, formulate management regulations on the packaging, storage, transportation, utilization and supervision of unqualified blood, and further improve China's unpaid blood donation system.
Chang Juping suggested that the Standing Committee of the National People's Congress revise some of the following provisions of the Blood Donation Law. The third paragraph of Article 10 is proposed to be amended as: "Blood stations must test the collected blood, and blood that has not been tested or failed to pass the test shall not be provided to medical institutions. The utilization and supervision of unqualified blood shall be separately formulated by the competent administrative department of health and health. ”
In addition, it is suggested that Article 11 be amended to read: "The blood of unpaid blood donation shall not be bought and sold, and qualified blood must be used for clinical purposes; For blood other than clinical use, the relevant blood stations and medical institutions shall not give apheresis plasma stations or blood product production units, and shall be effectively used in accordance with relevant regulations. ”